IRIS Accounts Production v24.1.9.2 03851907 Board of Directors 1.1.23 31.12.23 31.12.23 13.9.24 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh038519072022-12-31038519072023-12-31038519072023-01-012023-12-31038519072021-12-31038519072022-01-012022-12-31038519072022-12-3103851907ns15:EnglandWales2023-01-012023-12-3103851907ns14:PoundSterling2023-01-012023-12-3103851907ns10:Director12023-01-012023-12-3103851907ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3103851907ns10:SmallEntities2023-01-012023-12-3103851907ns10:Audited2023-01-012023-12-3103851907ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3103851907ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3103851907ns10:FullAccounts2023-01-012023-12-3103851907ns10:Director22023-01-012023-12-3103851907ns10:CompanySecretary12023-01-012023-12-3103851907ns10:RegisteredOffice2023-01-012023-12-3103851907ns5:CurrentFinancialInstruments2023-12-3103851907ns5:CurrentFinancialInstruments2022-12-3103851907ns5:ShareCapital2023-12-3103851907ns5:ShareCapital2022-12-3103851907ns5:RetainedEarningsAccumulatedLosses2023-12-3103851907ns5:RetainedEarningsAccumulatedLosses2022-12-3103851907ns5:FurnitureFittings2023-01-012023-12-3103851907ns5:FurnitureFittings2022-12-3103851907ns5:FurnitureFittings2023-12-3103851907ns5:FurnitureFittings2022-12-3103851907ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3103851907ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-31
REGISTERED NUMBER: 03851907 (England and Wales)















Financial Statements for the Year Ended 31 December 2023

for

Vibrant Medical Limited

Vibrant Medical Limited (Registered number: 03851907)






Contents of the Financial Statements
for the Year Ended 31 December 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Vibrant Medical Limited

Company Information
for the Year Ended 31 December 2023







DIRECTORS: P J Ellin
Mrs L Parry





SECRETARY: D R Jones





REGISTERED OFFICE: Unit 1 Colomendy Industrial Estate
Rhyl Road
Denbigh
Denbighshire
Clwyd
LL16 5TS





REGISTERED NUMBER: 03851907 (England and Wales)





AUDITORS: JWR Audit Limited
Statutory Auditor
24 Picton House
Hussar Court
Waterlooville
Hampshire
PO7 7SQ

Vibrant Medical Limited (Registered number: 03851907)

Balance Sheet
31 December 2023

31.12.23 31.12.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 - (158 )

CURRENT ASSETS
Debtors 5 35,751 32,763

CREDITORS
Amounts falling due within one year 6 1,192,573 3,404,197
NET CURRENT LIABILITIES (1,156,822 ) (3,371,434 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(1,156,822

)

(3,371,592

)

CAPITAL AND RESERVES
Called up share capital 325,434 325,434
Retained earnings (1,482,256 ) (3,697,026 )
SHAREHOLDERS' FUNDS (1,156,822 ) (3,371,592 )

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 September 2024 and were signed on its behalf by:





P J Ellin - Director


Vibrant Medical Limited (Registered number: 03851907)

Notes to the Financial Statements
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

Vibrant Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Monetary amounts in these financial statements are rounded to the nearest whole £1, except where otherwise indicated.

Turnover
Turnover represents the value of goods sold to customers during the year net of discounts and value added tax. Turnover is recognised upon delivery of goods to its customers.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - at varying rates on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Vibrant Medical Limited (Registered number: 03851907)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

2. ACCOUNTING POLICIES - continued

Going concern
The company's business activities, together with the factors likely to affect its future development and position, are set out in the Business Review section of the directors report in the consolidated financial statements.

The company had net liabilities at the end of the year. The company participates in the group's centralised treasury arrangements and so shares banking arrangements with its parent and fellow subsidiaries.

The directors, having assessed the responses of the directors of the company's parent NHC Holdings Limited to their enquiries have no reason to believe that a material uncertainty exists that may cast significant doubt about the ability of the NHC Holdings Limited group to continue as a going concern or its ability to continue with the current banking arrangements.

On the basis of their assessment of the company's financial position and of the enquiries made of the directors of NHC Holdings Limited, the company directors have a reasonable expectation that the company will be able to continue in operational existence for the foreseeable future. Thus the going concern basis of accounting in preparing the annual financial statements has been used.

The ultimate parent company NHC Holdings Limited has confirmed its intention to support the company in meeting its liabilities as they fall due, and consequently the financial statements have been prepared on the going concern basis.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2022 - 4 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1 January 2023 154
Disposals (154 )
At 31 December 2023 -
DEPRECIATION
At 1 January 2023 312
Eliminated on disposal (312 )
At 31 December 2023 -
NET BOOK VALUE
At 31 December 2023 -
At 31 December 2022 (158 )

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade debtors 4,731 1,743
Other debtors 31,020 31,020
35,751 32,763

Vibrant Medical Limited (Registered number: 03851907)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade creditors (1 ) -
Amounts owed to group undertakings 1,191,199 3,401,557
Taxation and social security 1,375 2,071
Other creditors - 569
1,192,573 3,404,197

7. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

K S Wood (Senior Statutory Auditor)
for and on behalf of JWR Audit Limited

8. CONTINGENT LIABILITIES

The company has given composite cross guarantees relating to the bank borrowing of certain subsidiary companies. These borrowings amounted to £nil at the year end.

9. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

NHC Holdings Limited, whose registered office is the same as Vibrant Medical Limited, is the ultimate parent company and draws up consolidated group financial statements of which Vibrant Medical Limited is a member.

10. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is the board of directors.